InvestSMART

Adherium Limited (ASX: ADR) - Share Price

- Current share price for ADR : $0.048

Adherium Limited (ADR) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a provider of integrated digital health solutions and connected respiratory medical devices. Adherium's Hailie platform solution provides clinicians, healthcare providers and patients access to remotely monitor medication usage parameters and adherence, supporting reimbursement for qualifying patient management.

ADR General Information +

ASX Code ADR
Website http://www.adherium.com
Industry/Sector Health Care Technology
Market Cap ($M) 2
ADR Share Price $0.048
Day High $0.050
Day Low $0.048
Last Close $0.048
ADR Share Price Movement - ( No change )
Prices as at 16:40, 18 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Adherium Limited (ADR) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 3.25¢ 100% 15 Sep 2016 4 Oct 2016 - - -
Result 1.25¢ 100% 23 Mar 2016 7 Apr 2016 - - -

See all dividends from Adherium Limited (ADR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Adherium Limited (ADR) price-sensitive announcements

ADR - Quarterly Activities/Appendix 4C Cash Flow Report
Adherium Limited’s Appendix 4C and quarterly activities report for Q1 FY27, ended 30 Septe
Adherium Limited (ADR)
30 Oct 2026 | 5:39 PM
ADR - Preliminary Final Report
Adherium Limited’s Appendix 4E Preliminary Final Report for the financial year ended 30 Ju
Adherium Limited (ADR)
31 Aug 2026 | 7:07 PM
ADR - Adherium enters into additional $1M short-term loan facility
Adherium Limited has secured an additional AUD $1 million short-term unsecured loan facili
Adherium Limited (ADR)
18 Aug 2026 | 8:57 AM
ADR - Adherium Announces CEO Transition
Adherium Limited, a leader in digital respiratory management, announced the transition of
Adherium Limited (ADR)
29 Jul 2026 | 12:06 PM

Adherium Limited (ADR) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Adherium Limited (ADR)
ORDINARY FULLY PAID
Health Care $3 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 5:39PM $0.067 $0.048 fallen by 28.36%
Adherium Limited (ADR)
ORDINARY FULLY PAID
Health Care $3 Additional $750,000 Loan Facility from Barvest Ventures 30 Oct 2026 4:24PM $0.067 $0.048 fallen by 28.36%
Adherium Limited (ADR)
ORDINARY FULLY PAID
Health Care $3 Notice of Annual General Meeting/Proxy Form 29 Oct 2026 8:54AM $0.067 $0.048 fallen by 28.36%
Adherium Limited (ADR)
ORDINARY FULLY PAID
Health Care $3 Partnership with Florida Lung, Asthma & Sleep Specialists 26 Oct 2026 9:38AM $0.063 $0.048 fallen by 23.81%
Adherium Limited (ADR)
ORDINARY FULLY PAID
Health Care $3 Appointment of Chief Financial Officer 12 Oct 2026 10:10AM $0.077 $0.048 fallen by 37.66%
Adherium Limited (ADR)
ORDINARY FULLY PAID
Health Care $3 AUD$700,000 Short-Term Loan Facility from Barvest Ventures 7 Oct 2026 8:22AM $0.075 $0.048 fallen by 36%

ADR Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$14.16 -$0.30 -99.80% 0.00 0.00 0.00% 0.0%
2025A -$12.68 -$139.90 -29.40% 0.00 0.00 0.00% 0.0%
2024A -$10.22 -$198.30 -20.30% 0.00 0.00 0.00% 0.0%

ADR Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
4DMedical Limited (4DX) $1,319M 1.7823 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Adherium Limited (ADR) $3M -0.9981 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Artrya Limited (AYA) $501M -0.0450 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $21,067M 1.3034 -0.2811 0.2395 79.5189 110.6138 89.2380 0.34% 0.46% 0.57%

ADR Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 -240.00 0.00
Market 0.28 13.10 1.03 0.75
Sector 0.67 20.90 1.94 2.65

ADR Directors

Name Position Start Date
Mr Louis (Lou) James Panaccio Non-Executive Director 25 Feb 2022
Mr Jeremy Curnock-Cook Non-Executive Director 17 Apr 2015
Mr Keven Gessner Non-Executive Director 8 May 2025
Ms Victoria Durrans Non-Executive Director 1 Jun 2026
Mr George Baran Non-Executive Director, Non-Executive Chairman 13 May 2021

Adherium Limited (ADR) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
22 Jun 2026 BARAN, George Issued Indirect Shares 105,331,536 $0.003 $315,994.608
22 Jun 2026 PANACCIO, Louis (Lou) Issued Indirect Shares 9,666,664 $0.003 $28,999.992
20 Mar 2026 BARAN, George Issued Indirect Shares 22,371,011 $0.005 $111,855.055

See all changes in directors' interest & trades for Adherium Limited (ADR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

ADR Management

Name Position
John Perry Interim CEO
Priyamvada Sanjay Rasal (Pia) Joint Company Secretary
Anvi Mehta Joint Company Secretary
Thomas Quinlan Other Corporate Officer

ADR Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Adherium Limited (ADR). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
842,002,695 (15.34%) Trudell Medical Limited
743,454,736 (13.50%) Phillip Asset Management Ltd
465,348,040 (8.48%) Regal Partners Funds Management Pty Limited and its associates
276,349,521 (5.03%) UBS Group AG and its related bodies corporate

ADR Calendar of Events

Date Event
29 September 2027 Report (Annual)
30 August 2027 Report (Prelim)
26 February 2027 Report (Interim)
30 November 2026 AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.